Cardiac Drugs 2 Flashcards
Sodium Bicarbonate Class
Systemic hydrogen ion buffer, alkalizing agent
Sodium Bicarbonate Mechanism of Action
Buffers metabolic acidosis and lactic acid buildup in the body caused by anaerobic metabolism secondary to severe hypoxia by reacting with hydrogen ions to form water and carbon dioxide.
Sodium Bicarbonate Indications
Metabolic acidosis during cardiac arrest, trycyclic antidepressant, aspirin, and PHENobarbital overdose, hyperkalemia, crush injuries.
Sodium Bicarbonate Contraindications
Metabolic and respiratory alkalosis, hypokalemia, electrolyte imbalance due to severe vomiting or diarrhea.
Sodium Bicarbonate Adverse reactions/side effects
Hypernatremia, metabolic alkalosis, tissue sloughing, cellulitis, mecrosis at injection site, seizures, fluid retention, hypokalemia, electrolyte imbalance, tetany, sodium retention, peripheral edema.
Sodium Bicarbonate Drug interactions
increases the effects of amphetamines. Decreases the effects of benzodiazapines, tricyclic antidepressants. May deactivate sympathomimetics(DOPamine, EPINEPHrine, norepinephrine)
Sodium Bicarbonate Adult Dosage and administration
1 mEq/kg slow IV, IO push, may repeat at 0.5 mEQ/kg every 10 minutes.
Sodium Bicarbonate Pediatric Dosage and administration
1 mEq/kg slow IV, IO push(dilute in small children to 4.2%)
Sodium Bicarbonate Duration of Action
onset: seconds
peak effect: 1 to 2 minutes
duration: 10 minutes
Sodium Bicarbonate Pregnancy safety category
C
Sodium Bicarbonate Special Considerations
Repeat as needed in tricyclic antidepressant overdose until QRS narrows. Must be used in conjuction with effective ventilation and chest compressions in cardiac arrest. Avoid contact with other medications; may precipitate or inactivate them. Always flush IV line well before and after injecting. Use with caution in patients with heart failure and renal disease due to high sodium concentration. Monitor patient closely for signs and symptoms of fluid overload.
Furosemide (Lasix) class
loob diuretic
Furosemide (Lasix) Mechanism of Action
Blocks the absorption of sodium and chloride at the distal and proximal tubules and the loop of Henle, causing increased urine output
Furosemide (Lasix) Indications.
Heart failure, pulmonary edema, hypertensive crisis.
Furosemide (Lasix) Contraindications
hypovolemia, anuria, hypotension(relative contraindication), hypersensitivity, hepatic coma, suspected electrolyte imbalances.
Furosemide (Lasix) Adverse reactions/ side effects
Dizziness, headache, ECG changes, weakness, orthostatic hypotension, dysrhythmias, nausea, vomiting, diarrhea, dry mouth, may exacerbate hypovolemia and hypokalemia, hyperglycemia(due to hemoconcentration)
Furosemide (Lasix) Drug interactions
Lithium toxicity may be potentiated because of sodium depletion. Digitalis toxicity may be potentiated by potassium depletion.
Furosemide (Lasix) Adult Dosage and administration
0.5 to 1mg/kg IV over 1 to 2 minutes. If no response, double the dose to 2 mg/kg slowly over 1 to 2 minutes.
Furosemide (Lasix) Pediatric Dosage and Administration
1 mg/kg IV/IO
Furosemide (Lasix) Duration of action
onset: 5 minutes.
peak: 20-60 mins.
duration 4 to 6 hours.
Furosemide (Lasix) Pregnancy safety
C
Furosemide (Lasix) special considerations.
Should only be used during pregnancy if maternal benefit outweighs fetal risk. Ototoxicity, deafness and projectile vomiting can occur with rapid administration. Should be protected from light. Vasodilatory effects within 5 minutes; diuretic effects within 30 minutes. Expect 10 to 12 minutes. Expect to 10 12 mm Hg systolic and a 5 to 7 mm Hg diastolic drop in BP. Being phased out due to nephrotoxic side effects. Furosemide administration has decreased with the advent of CPAP.
Labetalol (Normodyne, Trandate) Class
Selective alpha and nonselective beta adrenergic blocker, antihypertensive
Labetalol (Normodyne, Trandate) Mechanism of action
BP reduction without reflex tachycardia; total peripheral resistance reduced without significant alteration in cardiac output
Labetalol (Normodyne, Trandate) Indications
Moderate to severe hypertension.
Labetalol (Normodyne, Trandate) Contraindications
Bronchial asthma, heart failure, cardiogenic shock, second and third degree heart block, bradycardia
Labetalol (Normodyne, Trandate) Adverse reactions/side effects
Fatigue, weakness, depression, headache, dizziness, bronchospasm, wheezing, dyspnea, bradycardia, heart failure, pulmonary edema, orthostatic hypotension, ventricular dysrhythmias, nausea, vomiting, diarrhea.
Labetalol (Normodyne, Trandate) Drug Interactions
Labetalol may block bronchodilator effects of beta adrenergic agonists. NTG may augment hypotensive effects.
Labetalol (Normodyne, Trandate) Adult Dosage and Administration
10 mg IV push over 1 to 2 minutes. May repeat or double every 10 minutes to a maximum dose of 150 mg.
or infusion of 2 to 8 mg/min, titrated to supine BP.
Labetalol (Normodyne, Trandate) Pediatric Dosage and administration
Not recommended.
Labetalol (Normodyne, Trandate) Duration of action
onset: Less than 5 minutes
peak: Variable
duration: 3 to 6 hours.
Labetalol (Normodyne, Trandate) pregnancy safety category
C
Labetalol (Normodyne, Trandate) Special considerations
BP, pulse rate, and ECG should be monitored continuously. Observe for signs of heart failure, bradycardia, and bronchospasm. Should only be administered with patient in the supine position.
Metroprolol Tartrate (Lopressor) Class
Beta blocker, beta 1 selective
Metroprolol Tartrate (Lopressor) Mechanism of action
decreases heart rate, conduction velocity, myocardial contractility, and cardiac output. Used to control ventricular response in SVT(PSVT, AF, atrial flutter) Considered second line agent after adenosine, diltiazem, or digitalis derivative.
Metroprolol Tartrate (Lopressor) Indications
PSVT, atrial flutter, AF, reduces myocardial ischemia and damage in patients with AMI.
Metroprolol Tartrate (Lopressor) Contraindications
heart failure, second or third degree AV block, first degree heart block (if PR interval is equal to or greater than 0.24), sick sinus syndrome, cardiogenic shock, bradycardia.
Metroprolol Tartrate (Lopressor) Adverse reactions/ side effects
weakness, dizziness, depression, bronchospasm, wheezing, dyspnea, bradycardia, pulmonary edema, heart failure, AV blocks, hypotension, nausea, indigestion
Metroprolol Tartrate (Lopressor) Drug Interactions
Metoprolol may potentiate antihypertensive effects when given to patients taking calcium channel blockers or MAOIs. Catecholamine depleting drugs may potentiate hypotension
Metroprolol Tartrate (Lopressor) Adult Dosage and Administration
5 mg IV over 1 to 2 minutes. May repeat as needed every 5 minutes for a total of three doses.